Baker Avenue Asset Management’s Novartis NVS Stock Holding History

Baker Avenue Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-387	Closed	-$39.4K	–	1118
2023 Q3	$39.4K	Sell	387 -60	-13%	-$6.09K	﹤0.01%	555
2023 Q2	$45.1K	Buy	447 +16	+4%	+$1.6K	﹤0.01%	541
2023 Q1	$39.6K	Sell	431 -29	-6%	-$2.53K	﹤0.01%	564
2022 Q4	$41.7K	Buy	+460	New	+$38.7K	﹤0.01%	518
2022 Q2	–	Sell	-4,356	Closed	-$382K	–	319
2022 Q1	$382K	Buy	4,356 +956	+28%	+$82.8K	0.02%	245
2021 Q4	$297K	Buy	3,400 +246	+8%	+$20.4K	0.01%	267
2021 Q3	$257K	Buy	+3,154	New	+$284K	0.01%	228
2015 Q4	–	Sell	-41,396	Closed	-$3.41M	–	200
2015 Q3	$3.41M	Sell	41,396 -1,310	-3%	-$117K	0.6%	48
2015 Q2	$3.76M	Sell	42,706 -3,751	-8%	-$344K	0.5%	66
2015 Q1	$4.11M	Sell	46,457 -1,182	-2%	-$105K	0.54%	51
2014 Q4	$3.96M	Sell	47,639 -2,023	-4%	-$168K	0.55%	51
2014 Q3	$4.19M	Buy	49,662 +106	+0.2%	+$8.58K	0.59%	40
2014 Q2	$4.02M	Buy	49,556 +530	+1%	+$41.7K	0.58%	41
2014 Q1	$3.73M	Buy	49,026 +1,629	+3%	+$119K	0.59%	46
2013 Q4	$3.41M	Buy	47,397 +1,010	+2%	+$70.2K	0.66%	41
2013 Q3	$3.19M	Buy	+46,387	New	+$3.07M	0.67%	43

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baker Avenue Asset Management's NVS Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Novartis (NVS) in Q4 2023, closing a stake of 387 shares — an estimated $39.4K sold.

Baker Avenue Asset Management first reported a position in NVS in Q3 2013 and held it in 16 quarters. The position peaked at $4.19M in Q3 2014. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

Baker Avenue Asset Management reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
Baker Avenue Asset Management sold 387 Novartis shares in Q4 2023, an estimated $39.4K.
Baker Avenue Asset Management first reported a position in Novartis in Q3 2013 and held it in 16 quarters.
Baker Avenue Asset Management's Novartis position peaked at $4.19M in Q3 2014.
1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.